Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Capital Expenditures (2024 - 2025)

Historic Capital Expenditures for CG Oncology (CGON) over the last 2 years, with Q3 2025 value amounting to $97000.0.

  • CG Oncology's Capital Expenditures rose 980000.0% to $97000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $336000.0, marking a year-over-year change of. This contributed to the annual value of $234000.0 for FY2024, which is N/A changed from last year.
  • As of Q3 2025, CG Oncology's Capital Expenditures stood at $97000.0, which was up 980000.0% from $14000.0 recorded in Q2 2025.
  • CG Oncology's Capital Expenditures' 5-year high stood at $209000.0 during Q4 2024, with a 5-year trough of -$1000.0 in Q3 2024.